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Global Network for Women’s and Children’s
Health Research (U01)
The NICHD invites applications from investigators will-
ing to participate under a cooperative agreement in an
ongoing multicenter international research network
designed to perform randomized clinical trials of inter-
ventions to reduce the major risks to maternal, neonatal,
infant, and early childhood health in resource-poor
countries. The purpose of this solicitation is to comple-
ment the existing Global Network with the addition of
research units (RUs) from Africa and India. The objec-
tive of this program is to contribute to the resolution of
maternal and pediatric health problems by establishing a
network of RUs (paired U.S.-based and foreign centers)
that will use common protocols to implement random-
ized clinical trials and thus contribute to the evidence
base for sound clinical, programmatic, and policy deci-
sions. The network will establish the infrastructure neces-
sary to initiate, implement, and evaluate randomized
controlled trials in community settings and health care
facilities among pregnant women, newborns, infants,
and children to the age of 3 years.
The overall goal of the network is to expand scien-
tiﬁc knowledge relevant to improving health outcomes
for women and children in developing countries. Other
critical goals are to: 1) develop sustainable research infra-
structure and public health intervention capabilities in
developing countries and 2) strengthen international col-
laborative research arrangements that focus on the leading
causes of morbidity and mortality in pregnancy and early
childhood. A key objective for the network RUs is to
design, develop, and conduct multiple simultaneous com-
mon clinical trials, as well as to evaluate and implement
evidence-based health interventions and pertinent forma-
tive and translational research studies collaboratively.
These studies must have a strong scientiﬁc and epidemio-
logic basis for their use in a foreign country, and should
be culturally appropriate. The primary end points in these
studies must be associated with demonstrable improve-
ment in important public health measures in the popula-
tion under study. This network will bring the required
numbers of subjects into rigorously designed common
protocols and thus address pressing research questions in
pregnant women and very young children more quickly
and efﬁciently than could individual centers acting alone.
Research that is predominantly epidemiologic,
such as observational or surveillance studies, will not be
reviewed and will be returned to the PI as unresponsive
to the RFA. Applications that propose only to evaluate
health care delivery programs or health care utilization
and do not evaluate a human experimental intervention
will also be considered as non-responsive and will be
returned without review. Program staff will assist the
PIs and the SFIs of the Global Network for Women's
and Children's Health Research (GN) to identify
research topics of high priority, and to design, imple-
ment, and evaluate the impact of common protocols.
According to a report of the Global Forum for
Health Research, > 1.3 billion of the approximately 6
billion people alive today live in extreme poverty. Nearly
3 billion people live on < $2 a day, and 70% of these
poor are women. Frequently in poor health, they live in
unsafe and unsanitary conditions, have the primary
responsibility for caring for children and the elderly, and
are often expected to perform the major tasks of family
sustenance. Despite successes during the past 30 years in
improving the health of women and children worldwide,
interventions are needed to avert the continuing unnec-
essary, preventable deaths, illness, and disability that dis-
proportionately affect poor women and children,
especially in the developing world.
Problems at the home and community level con-
tribute to maternal, neonatal, and child morbidity and
mortality. These include underlying nutritional deﬁcits,
limited access to quality medical care, inadequately
trained health care workers, lack of adequate health
information and resources, social and cultural norms,
civil and domestic violence, and the low social status of
women and children.
According to World Bank reports, maternal mortal-
ity remains the human development indicator that shows
the greatest gap between developing and developed coun-
tries. The health problems that contribute most to mater-
nal deaths in the developing world include intrapartum
bleeding, sepsis, eclampsia, obstructed labor, and postpar-
tum hemorrhage. The World Health Organization
(WHO) estimates that every year > 500,000 women die
as a result of pregnancy-related complications, most due
to postpartum hemorrhage or infection. This represents
one in 16 women in developing countries dying of preg-
nancy-related complications, compared with one in every
2,800 women in developed countries. Seventy percent of
women receive no postpartum care in the 6 weeks
following delivery.
For every woman who dies, an estimated 15–30
survive but suffer chronic disabilities and morbidities.
This includes obstetric fistula, one of the most com-
mon, painful, and stigmatizing disabilities. Obstetric
fistula affects approximately 2 million women, with
50,000–100,000 new cases per year.
Improving maternal health in the developing world
is of utmost importance for the woman's own sake, and
because the death of a reproductive age woman signiﬁ-
cantly lowers the chance of survival of her infants and
children. The WHO estimates that approximately 8
million infants die each year, and of these, more than
half (4.4 million) die within the ﬁrst 28 days of life. 
Ninety-eight percent of these deaths occur in devel-
oping countries and are caused by infectious diseases;
pregnancy-related conditions; and delivery-related com-
plications, including intrapartum asphyxia, birth
trauma, and premature birth. Birth asphyxia accounts
for 21% of deaths, followed by pneumonia (19%) and
neonatal tetanus (14%). These deaths are preventable if
women and their neonates have access to trained health
care workers for delivery, immunizations, and timely
treatment of infections.
An estimated 10 million children < 5 years of age,
primarily in developing countries, die each year from
infectious diseases, nutrition-related illnesses, and perina-
tal complications. These conditions, and others associ-
ated with early childhood, are expected to remain the
major causes of mortality in young children through
2020. Two-thirds of these illnesses and deaths are pre-
ventable, yet they are associated with about half of the
disease burden in the poorest regions of the world,
including India and sub-Saharan Africa, where the rate
of improvement in child mortality is actually slowing.
Infectious diseases account for 63% of deaths in
children < 5 and many, such as tuberculosis and malaria,
have become more difficult to treat due to increased
resistance to commonly used and available antimicrobial
drugs. The WHO estimates that 10,000 maternal deaths
and 200,000 infant deaths each year in the developing
world are associated with malaria infection during preg-
nancy. Lower immunity during pregnancy puts women
at increased risk for malaria, which is associated with
intrauterine growth retardation, increased fetal losses,
susceptibility to other illnesses and death. Over 40% of
the world's children live in malaria endemic areas. The
WHO estimates that malaria causes approximately 20%
of all childhood deaths in Africa. Despite increased resis-
tance to antimalarial drugs, many of these deaths are still
preventable with appropriate interventions.
Because > 40% of the world’s children live in
malaria endemic areas, older children are also at risk. In
developing countries, where an estimated 63% of infants
are born at home and an estimated 80% of children die
at home, advice and assistance concerning reproductive
health, birth practices, and infant and child care may be
available only from local community health workers, tra-
ditional medical practitioners, or members of a woman's
extended family. Research is needed to identify interven-
tions that can be delivered in community and primary
care settings because referral and transport to higher level
institutional care are often unavailable.
Toxic environmental exposures, including cooking
smoke and tobacco exposure, represent an increasing
threat to women. Women comprise > 200 million of the
world's 1.2 billion cigarette smokers. Maternal cigarette
smoking is associated with perinatal mortality, low birth
weight, premature delivery, and other adverse outcomes,
while environmental tobacco smoke exposure (ETS)
poses a serious risk to infants and young children as well
as to adults. Although female smoking prevalence is still
quite low in many developing countries, it appears to be
increasing, and women's use of other forms of tobacco is
common in some regions. Research is needed on inter-
ventions to prevent and reduce tobacco use and on ETS
exposure among pregnant and reproductive age women
and girls in developing countries.
Given the alarming rates of morbidity and mortality
in women and children in the developing world, ran-
domized clinical trials testing innovative interventions
are urgently needed to help improve the health of
women and children in these countries. In some
instances, the results of efﬁcacy studies have not been
translated into feasible interventions for resource-poor
settings where the burden of these conditions is the heav-
iest. In other cases, feasible interventions have been
developed, but they are relatively ineffective, or effective-
ness has not been assessed. Because economic investment
in early intervention is warranted, and in many situations
is relatively inexpensive, rigorously tested health interven-
tions can have enormous impact. A global network of
U.S. and developing country scientist teams and institu-
tions will facilitate high quality, sustainable, collaborative
research that can address many of these problems and
issues while simultaneously building the professional
capacity and infrastructure in developing country sites.
Originally funded to perform site-speciﬁc diverse
individual protocols, the GN has transitioned to the con-
duct of common research protocols to more efﬁciently
build research capacity and address the major causes of
morbidity and mortality among women and young chil-
dren in the developing world. Grantees will be part of a
GN that will include clinical RUs and a Data
Coordinating Center. The GN is intended to strengthen
and expand the global infrastructure for women's and
children's health research. It will increase opportunities
for scientiﬁc linkages, interaction, knowledge develop-
ment and transfer, and collaborative partnerships among
U.S. and foreign investigators and institutions.
This initiative calls for a broad array of interven-
tional studies conducted across sites in the developing
countries selected. The studies should address health
conditions in women and young children, with an
emphasis on the perinatal and neonatal periods, but up
to and including 3 years of age. Proposed interventions
should emphasize the development, testing, and adapta-
tion of cost-effective, integrated biomedical, behavioral,
social, and public health interventions that may reduce
causes of premature morbidity and mortality among
women of reproductive age and young children.
Applications based predominantly in basic laboratories
in the United States will not be considered responsive to
the RFA. Studies focused on health interventions per-
formed at the community and primary health care level
are of particular interest to the GN.
The GN will function as an afﬁliated group that
fosters communication, innovation, and research excel-
lence. Applications for meritorious common research
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one locality will be reviewed and funded under the net-
work. Grantees should expect to propose and participate
in multiple common protocols that may be conducted in
several or all network sites. Grantees must be willing to
work collaboratively and with cultural sensitivity.
All research conducted under the auspices of the
GN must be designed such that health improvements
in the study population are meaningful, sustainable,
and likely to represent a measurable and signiﬁcantly
improved health outcome. Surrogate or intermediate
outcomes must be well deﬁned and scientiﬁcally well
justiﬁed.
The GN emphasizes a multidisciplinary, team-
based approach. Disciplines may include pediatrics, fam-
ily medicine, obstetrics, infectious diseases,
epidemiology, statistics, environmental science, pharma-
cology, and the behavioral and social sciences. GN teams
should be based primarily at the institution of the SFI. It
is not the intention of this RFA to support multidiscipli-
nary teams of investigators in the United States.
Priority will be given to scientiﬁc activities that have
the greatest likelihood of improving pregnancy and child
outcomes in developing countries. Suitable topics for pro-
posed research projects include, but are not limited to, the
following: 1) prevention or reduction of leading causes of
maternal morbidity and mortality, including but not lim-
ited to, malnutrition, infectious diseases, hypertensive dis-
orders, obstructed labor, postpartum hemorrhage, cervical
cancer, and cancers exacerbated by environmental expo-
sures; 2) studies focused on assessing and improving preg-
nancy management, including reduction of infection,
emergency care, birth practices, resuscitation, and post-
partum care of the mother, neonate, and young infant; 3)
prevention and reduction of fetal loss, stillbirths, preterm
delivery, and birth defects; 4) prevention and treatment of
infectious diseases in infants and young children up to 3
years, including, but not limited to, sepsis, malaria and
other parasitic diseases, diarrheal diseases, acute respira-
tory tract infections, and vaccine-preventable infections;
5) within GN clinical trials, conduct research that
describes major individual, social and cultural factors
(such as belief systems, affordability, availability, and
access) inﬂuencing health-seeking behavior; 6) nutritional
interventions that enhance pregnancy outcomes and
infant growth, development, energy, and immunity; 7)
early interventions to enhance child outcomes, including
parental caretaking and parental mental health; 8) preven-
tion and treatment of environmental exposures in girls
and women of reproductive age and young children up to
3 years, including, but not limited to, tobacco, indoor
pollution, toxic chemicals, and water-borne infectious
agents; 9) studies to evaluate cost-effective, new rapid
diagnostic methodologies (e.g., tests for sepsis, malaria,
tuberculosis, etc., and verbal autopsy) available to
improve identiﬁcation of maternal, infant, and young
child morbidity, and/or mortality.
To provide an idea of the capabilities of the
applicant RUs to participate in the development and
design of cooperative protocols, each applicant should
propose one fully developed common research study
to address a current critical or emerging health prob-
lem related to the needs of women and/or young chil-
dren in the foreign collaborator's country and other
developing countries. The protocol should be appro-
priate for the GN in that it requires a multicenter
design. The application should provide a research
plan that includes an evidence-based statement of the
health problem (including preliminary data); research
hypothesis; speciﬁc aims; proposed study population;
study design, methodology, and recruitment plans;
data collection, analysis, and reporting plans; sug-
gested timelines and stafﬁng plans; plans for enhanc-
ing research capacity at the foreign sites; plans for
sustaining the intervention after the funding period is
over; and a proposed budget for the life of the project.
Evidence of collaboration and multidisciplinary exper-
tise should be provided. It is critically important that
the proposed intervention be community or primary
care facility-based and not place undue burden on the
population or cause disruption of local facilities. The
quality of the research plan will be an important focus
of the peer review of the application. There is no
guarantee that the proposed research plan will be
accepted as a common protocol by the GN. However,
funded RUs will be invited to submit the protocols
from their application to the Protocol Review
Subcommittee and Steering Committee for review
and consideration. The Global Network Data
Coordinating Center will assist in data collection and
management, including statistical expertise, and
research protocol management.
The NICHD expects that ongoing common pro-
tocols of the currently-funded GN may continue into
the continuation grant period in existing centers. New
common protocols may be developed before the start
of the continuation. Research sites that join the net-
work during the next award period (beginning
approximately 1 April 2008) may participate in the
protocols ongoing at that time, as appropriate.
The NICHD expects the network to initiate new
common protocols in the ﬁrst year. The topics of these
protocols will be decided and prioritized cooperatively
by the Global Network Steering Committee and
implemented after internal NIH review.
This RFA solicits applications for pairs of U.S.
and developing country research sites to form a
research network to address the major causes of mater-
nal, neonatal, infant, and early childhood morbidity
and mortality. The grantees will form a cooperative
network in scientiﬁc partnership with NICHD to con-
duct common randomized clinical trials evaluating
interventions in resource-poor settings. The catchment
populations for the sites will include a diversity of eth-
nic, linguistic, and cultural groups.
Organizational Components. The GN consists of
multiple RUa composed of multidisciplinary teams of
collaborating U.S. scientists linked to investigators in
developing countries as full and equal partners; a sin-
gle Data Coordinating Center that will provide
research support services and methodological and sta-
tistical expertise for the GN; and the NIH (repre-
sented by the NICHD Program Scientist and Staff
Science Collaborators from NICHD.) The GN RUs
may include additional consultants needed at speciﬁc
time periods.
Steering Committee. The steering committee will
serve as the GN’s central point of communication;
exchange of ideas; development, review, and manage-
ment of common protocols; research and training
activities; and problem resolution. The steering com-
mittee reviews all presentations and publications via
the publications subcommittee and NICHD clearance
mechanisms. The steering committee is composed of
the U.S. PI and SFI of each RU, the PI of the Data
Coordinating Center, and the NICHD Program
Scientist, each of whom have one vote. NICHD will
appoint a chairperson who is not participating as a PI
for a minimum term of one year.
The steering committee will meet twice annually
in person and will participate in telephone or video
conferences as needed between steering committee
meetings. During the meetings, research progress and
problems are reviewed for each site.
Data Coordinating Center. The GN Data
Coordinating Center has the responsibility to provide
the network's organizational, statistical, and technical
support, including the shared funding of information
technology staff and site training, and regulatory adher-
ence. In addition, the Data Coordinating Center will
ﬁnancially support specialty consultations, specialty ser-
vices, and other study needs. It also is responsible for
assisting the sites in developing and implementing com-
mon protocols, implementing quality assurance proce-
dures, including site monitoring; developing data
management systems and databases; and developing
analytic capacity. The Data Coordinating Center will be
responsible for the creation and integrity of study data-
bases, analytic capacity, and support of and attendance
at all network meetings.
Data and Safety Monitoring Board. A Data and
Safety Monitoring Board (DSMB) has been estab-
lished by NICHD to monitor the safety of ongoing
clinical trials. It also advises the NIH and the GN,
including the Data Coordinating Center, on research
design issues, data quality and analysis, and ethical
and human subject issues. The DSMB members have
expertise in clinical trial design and conduct; relevant
basic, medical, and behavioral sciences research; and
ethics and cultural competency issues, particularly
with relevance to developing country populations.
The Data Coordinating Center provides coordina-
tion, support, travel funding, and logistical arrange-
ments for DSMB meetings and actions.
In addition, the network has established policies
and procedures that govern its operations, including
publication. These documents are under periodic
review, and may be amended and supplemented at the
discretion of the NICHD and the steering committee.
This funding opportunity will use the NIH
Cooperative Research Project Grant (U01) award
mechanism.
This funding opportunity uses the just-in-time bud-
get concepts. It also uses the nonmodular budget format
described in the PHS 398 application instructions (see
http://grants.nih.gov/grants/funding/phs398/phs398.
html). A detailed categorical budget for the “Initial
Budget Period” and the “Entire Proposed Period of
Support” is to be submitted with the application.
The NIH U01 is a cooperative agreement award
mechanism. In the cooperative agreement mechanism,
the PI retains the primary responsibility and dominant
role for planning, directing, and executing the proposed
project, with NIH staff being substantially involved as a
partner with the PI, as described under the Section VI.
2. Administrative Requirements, “Cooperative
Agreement Terms and Conditions of Award.”
The PHS 398 application instructions are available
at http://grants.nih.gov/grants/funding/phs398/
phs398.html in an interactive format. Applicants must
use the currently approved version of the PHS 398. For
further assistance contact GrantsInfo, 301-435-0714
(telecommunications for the hearing impaired: TTY
301-451-0088) or by e-mail: GrantsInfo@nih.gov.
Applications must be prepared using the most cur-
rent PHS 398 research grant application instructions
and forms. Applications must have a Dunn and
Bradstreet (D&B) Data Universal Numbering System
(DUNS) number as the universal identiﬁer when apply-
ing for Federal grants or cooperative agreements. The
D&B number can be obtained by calling 866-705-5711
or through the web site at http://www.dnb.com/us/.
The D&B number should be entered on line 11 of the
face page of the PHS 398 form.
The letter of intent date for this RFA is 26 June
2007, with the application receipt date 27 July 2007. The
complete version of this RFA is available at http://grants.
nih.gov/grants/guide/pa-ﬁles/RFA-HD-07-016.html.
Contact: Linda L. Wright, Center for Research for
Mothers and Children, National Institute of Child Health
and Human Development, 6100 Executive Boulevard,
Room 4B05, MSC 7510, Bethesda, MD 20892-7510
USA, Rockville, MD 20852 USA (for express/courier ser-
vice), 301-402-0830, fax: 301-480-7773, e-mail:
wrightl@mail.nih.gov. Reference: RFA-HD-07-016.
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